A Flint woman may be the first in the world with leukemia to undergo a transplant using stem cells from the bone marrow of a ...
It's just a snippet of what happens on a Storylines’ wellness cruise, all in the name of longevity tourism—a rapidly growing ...
Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical ...
Gene and cell therapies bring fresh hope to people with genetic disorders, but recovery can be complex and long-term support ...
MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based ...
A new Cambridge biotech a decade in the making has launched with a plan to “revolutionize the field” of cell therapy based on ...
During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...
Syntax Bio has invented a modified CRISPR system that it says can transform cells more efficiently than current methods.
Children's Hospital of Michigan is treating the first person in Michigan with a newly approved gene-editing therapy for beta thalassemia.